Shiqiang Hou - Search Results

Year	Number of Results
2014	1
2016	1
2017	3
2018	5
2019	3
2020	6
2021	4
2022	3

1

EZH2 is a potential prognostic predictor of glioma.

Chen YN, Hou SQ, Jiang R, Sun JL, Cheng CD, Qian ZR. Chen YN, et al. J Cell Mol Med. 2021 Jan;25(2):925-936. doi: 10.1111/jcmm.16149. Epub 2020 Dec 4. J Cell Mol Med. 2021. PMID: 33277782 Free PMC article.

2

Pathological Grade-Associated Transcriptome Profiling of lncRNAs and mRNAs in Gliomas.

Sun J, Jiang R, Song M, Yao J, Hou S, Zhu Y, Ji X, Sheng H, Tang Z, Liu Q, Jia Z, Shi W, Shi J. Sun J, et al. Among authors: hou s. Front Oncol. 2020 Mar 10;10:253. doi: 10.3389/fonc.2020.00253. eCollection 2020. Front Oncol. 2020. PMID: 32211318 Free PMC article.

3

Profiling and Molecular Mechanism Analysis of Long Non-Coding RNAs and mRNAs in Pulmonary Arterial Hypertension Rat Models.

Hou S, Chen D, Liu J, Chen S, Zhang X, Zhang Y, Li M, Pan W, Zhou D, Guan L, Ge J. Hou S, et al. Front Pharmacol. 2021 Jun 29;12:709816. doi: 10.3389/fphar.2021.709816. eCollection 2021. Front Pharmacol. 2021. PMID: 34267668 Free PMC article.

4

A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.

Hou S, Niu G, Liu X, Bourbon PM, Zhang D, Cui P, Zhao K, Zhao D, Zeng H. Hou S, et al. Microvasc Res. 2021 Nov;138:104209. doi: 10.1016/j.mvr.2021.104209. Epub 2021 Jun 16. Microvasc Res. 2021. PMID: 34146582

5

Orphan nuclear receptor TR3/Nur77 biologics inhibit tumor growth by targeting angiogenesis and tumor cells.

Chen C, Li Y, Hou S, Bourbon PM, Qin L, Zhao K, Ye T, Zhao D, Zeng H. Chen C, et al. Among authors: hou s. Microvasc Res. 2020 Mar;128:103934. doi: 10.1016/j.mvr.2019.103934. Epub 2019 Oct 23. Microvasc Res. 2020. PMID: 31654655

6

Upregulation of miR-340 Inhibits Tumor Growth and Mesenchymal Transition via Targeting c-MET in Glioblastoma.

Lin N, Li W, Wang X, Hou S, Yu D, Zhao X, Jin C, Yao G, Yan W, You Y. Lin N, et al. Among authors: hou s. Cancer Manag Res. 2020 May 12;12:3343-3352. doi: 10.2147/CMAR.S250772. eCollection 2020. Cancer Manag Res. 2020. PMID: 32494198 Free PMC article.

7

A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining.

Liu J, Hou S, Wang J, Chai Z, Hong X, Zhao T, Sun Z, Bai L, Gao H, Gao J, Chen G. Liu J, et al. Among authors: hou s. Oxid Med Cell Longev. 2020 Dec 19;2020:8847226. doi: 10.1155/2020/8847226. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33414898 Free PMC article.

8

Orphan nuclear receptor TR3/Nur77 differentially regulates the expression of integrins in angiogenesis.

Ye T, Peng J, Liu X, Hou S, Niu G, Li Y, Zeng H, Zhao D. Ye T, et al. Among authors: hou s. Microvasc Res. 2019 Mar;122:22-33. doi: 10.1016/j.mvr.2018.10.011. Epub 2018 Nov 1. Microvasc Res. 2019. PMID: 30391133 Free PMC article.

9

Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma.

Bao Y, Yang M, Jin C, Hou S, Shi B, Shi J, Lin N. Bao Y, et al. Among authors: hou s. World Neurosurg. 2018 Nov;119:e710-e716. doi: 10.1016/j.wneu.2018.07.252. Epub 2018 Aug 6. World Neurosurg. 2018. PMID: 30092479

10

Combination Glioma Therapy Mediated by a Dual-Targeted Delivery System Constructed Using OMCN-PEG-Pep22/DOX.

Qian W, Qian M, Wang Y, Huang J, Chen J, Ni L, Huang Q, Liu Q, Gong P, Hou S, Zhu H, Jia Z, Shen D, Zhu C, Jiang R, Sun J, Yao J, Tang Z, Ji X, Shi J, Huang R, Shi W. Qian W, et al. Among authors: hou s. Small. 2018 Oct;14(42):e1801905. doi: 10.1002/smll.201801905. Epub 2018 Sep 14. Small. 2018. PMID: 30346089

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results